AWM Investment Company, Inc. 13D and 13G filings for INVO Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-09-08 4:34 pm Purchase |
2023-08-31 | 13G | INVO Bioscience, Inc. INVO |
AWM Investment Company, Inc. | 63,193 2.600% |
32,000![]() (+102.59%) |
Filing |
2023-02-14 1:43 pm Sale |
2022-12-31 | 13G | INVO Bioscience, Inc. INVO |
AWM Investment Company, Inc. | 31,193 5.100% |
-26,761![]() (-46.18%) |
Filing |
2022-02-11 2:58 pm Purchase |
2021-12-31 | 13G | INVO Bioscience, Inc. INVO |
AWM Investment Company, Inc. | 57,954 9.900% |
246![]() (+0.43%) |
Filing |
2021-05-11 4:08 pm Purchase |
2021-04-30 | 13G | INVO Bioscience, Inc. INVO |
AWM Investment Company, Inc. | 57,708 11.100% |
26,458![]() (+84.66%) |
Filing |
2021-02-12 11:12 am Purchase |
2020-12-31 | 13G | INVO Bioscience, Inc. INVO |
AWM Investment Company, Inc. | 31,250 6.500% |
31,250![]() (New Position) |
Filing |